Dr. Anuj Chawla, MD

Dr. Chawla practices at Acuity Eye Group in Bakersfield, California.

Dr. Chawla's NPI, 1083841027, was assigned on June 17, 2009. Dr. Chawla graduated from Tulane School of Medicine in 2009. Dr. Chawla holds California license A136993.

Dr. Chawla's primary practice is Acuity Eye Group, at 9500 Stockdale Hwy, Bakersfield, CA 93311 in Kern County. The practice phone is (661) 663-8500.

Dr. Chawla's primary practice is Acuity Eye Group in Bakersfield, California. Dmand AI also links Dr. Chawla to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chawla practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Chawla's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Chawla is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Chawla's licenses on file in 2 states: California and Florida.

Dmand AI lists age-related macular degeneration, cataract, conjunctivitis, dry eye, glaucoma, hypertensive retinopathy, laser destruction of retinal or choroid lesions and retinal detachment among the conditions Dr. Chawla treats.

CMS data shows 9,797 Medicare services from Dr. Chawla across 14 procedure codes in 2024, for 663 Medicare patients. Medicare paid $954,186 for them. Every service was in an office.

CMS counts 663 Medicare patients who saw Dr. Chawla in 2024. The largest group is 65 to 74, with 332 patients. 75% of them have diabetes, and 75% have high blood pressure. 77% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chawla's median patient age at 61, with 56% women.

In 2024, Dr. Chawla wrote 415 Medicare Part D claims for 83 patients. 67% of them were for generic drugs. CMS names the drug for 379 of them, across 7 drugs with 11 or more claims each, at $5,700 in total drug cost. In 2023, CMS named 632 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Chawla for performance year 2024, reported individually. Dr. Chawla accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Chawla in 2020. The most frequent topics are Tomography, Optical Coherence. Dr. Chawla's most frequent co-authors are Royce Harwood Johnson, MD, Michael Karp, MD and Philip J. Rosenfeld, MD.

CMS Open Payments shows 66 general payments to Dr. Chawla from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Alimera Sciences, Inc. paid the most, $905.

Dr. Chawla graduated from Tulane School of Medicine in 2009.

Dr. Chawla is in network with 20 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.